Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial. 21764327 Hofmann JN, Yu K, Bagni RK, Lan Q, Rothman N, Purdue MP Cytokine 2011 PLCO
Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 21750727 Wentzensen N, Black A, Jacobs K, Yang HP, Berg CD, Caporaso N, Peters U, Ragard L, Buys SS, Chanock S, Hartge P PLoS ONE 2011 PLCO
Potential role of HE4 in multimodal screening for epithelial ovarian cancer. 21917606 Urban N, Thorpe JD, Bergan LA, Forrest RM, Kampani AV, Scholler N, O'Briant KC, Anderson GL, Cramer DW, Berg CD, McIntosh MW, Hartge P, Drescher CW J. Natl. Cancer Inst. 2011 PLCO
Building multi-marker algorithms for disease prediction-the role of correlations among markers. 21918599 Pinsky PF, Zhu CS Biomark Insights 2011 PLCO
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. 21212059 Gunter MJ, Cross AJ, Huang WY, Stanczyk FZ, Purdue M, Xue X, Schoen R, Limburg PJ, Schatzkin A, Sinha R, Hayes RB Cancer Epidemiol. Biomarkers Prev. 2011 PLCO
The use of imputed values in the meta-analysis of genome-wide association studies. 21769935 Jiao S, Hsu L, Hutter CM, Peters U Genet. Epidemiol. 2011 PLCO
The landscape of recombination in African Americans. 21775986 Hinch AG, Tandon A, Patterson N, Song Y, Rohland N, Palmer CD, Chen GK, Wang K, Buxbaum SG, Akylbekova EL, Aldrich MC, Ambrosone CB, Amos C, Bandera EV, Berndt SI, Bernstein L, Blot WJ, Bock CH, Boerwinkle E, Cai Q, Caporaso N, Casey G, Cupples LA, … Nature 2011 PLCO
Equating quantitative emphysema measurements on different CT image reconstructions. 21928661 Bartel ST, Bierhals AJ, Pilgram TK, Hong C, Schechtman KB, Conradi SH, Gierada DS Med Phys 2011 NLST
Reduced lung-cancer mortality with low-dose computed tomographic screening. 21714641 National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD N. Engl. J. Med. 2011 NLST
The National Lung Screening Trial: overview and study design. 21045183 National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ Radiology 2011 NLST
The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death. 21782037 Marcus PM, Gareen IF, Miller AB, Rosenbaum J, Keating K, Aberle DR, Berg CD Contemp Clin Trials 2011 NLST
In vivo detection of acinar microstructural changes in early emphysema with (3)He lung morphometry. 21734160 Quirk JD, Lutey BA, Gierada DS, Woods JC, Senior RM, Lefrak SS, Sukstanskii AL, Conradi MS, Yablonskiy DA Radiology 2011 NLST
Quantitative CT assessment of emphysema and airways in relation to lung cancer risk. 21900623 Gierada DS, Guniganti P, Newman BJ, Dransfield MT, Kvale PA, Lynch DA, Pilgram TK Radiology 2011 NLST
Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). 22045816 Kramer BS, Berg CD, Aberle DR, Prorok PC J Med Screen 2011 NLST
Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. 22021510 Larke FJ, Kruger RL, Cagnon CH, Flynn MJ, McNitt-Gray MM, Wu X, Judy PF, Cody DD AJR Am J Roentgenol 2011 NLST
The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. 21057003 Atkinson JJ, Lutey BA, Suzuki Y, Toennies HM, Kelley DG, Kobayashi DK, Ijem WG, Deslee G, Moore CH, Jacobs ME, Conradi SH, Gierada DS, Pierce RA, Betsuyaku T, Senior RM Am. J. Respir. Crit. Care Med. 2011 NLST
A special program to increase the participation of Hispanics in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Tenorio SL, Gamito EJ, Ogden S, Quintela J, Ordonez E, Crawford ED, Lamerato L Hisp Health Care Int 2011 PLCO
Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Singh S, Pinsky P, Fineberg N, Gierada DS, Garg K, Sun Y, Nath PH Radiology 2011 NLST
Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. 21715603 Chaturvedi AK, Kemp TJ, Pfeiffer RM, Biancotto A, Williams M, Munuo S, Purdue MP, Hsing AW, Pinto L, McCoy JP, Hildesheim A Cancer Epidemiol. Biomarkers Prev. 2011 PLCO
Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial. 21242173 Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR Clin Trials 2011 NLST